The revenue forecast by NeoGenomics for FY24 is very close to the analyst estimates, which could indicate confidence in the company's growth trajectory and operational stability. This alignment with analyst expectations is likely to be viewed positively by investors, potentially leading to a positive short-term impact on the stock price.